Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
02.05.2017 23:38:00
|
Quest Diagnostics To Speak At The Deutsche Bank 42nd Annual Health Care Conference
MADISON, N.J., May 2, 2017 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Deutsche Bank 42nd Annual Health Care Conference in Boston. Mark Guinan, Executive Vice President and CFO, will discuss the company's vision, goals and two-point strategy to accelerate growth and drive operational excellence. The presentation is scheduled for Wednesday, May 3, 2017 at 9:20 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://edge.media-server.com/m/p/zaz2ofrk and to the public on the company's investor relations page which can be accessed at www.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until June 2, 2017.
About Quest Diagnostics
Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 43,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com.
Contacts:
Shawn Bevec (Investors): 973-520-2900
Dennis Moynihan (Media): 973-520-2800
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-deutsche-bank-42nd-annual-health-care-conference-300450090.html
SOURCE Quest Diagnostics

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
22.04.25 |
Optimismus in New York: So entwickelt sich der S&P 500 am Mittag (finanzen.at) | |
22.04.25 |
S&P 500-Wert Quest Diagnostics-Aktie: So viel hätte eine Investition in Quest Diagnostics von vor 5 Jahren abgeworfen (finanzen.at) | |
22.04.25 |
Optimismus in New York: Anleger lassen S&P 500 zum Handelsstart steigen (finanzen.at) | |
21.04.25 |
Ausblick: Quest Diagnostics legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
15.04.25 |
S&P 500-Papier Quest Diagnostics-Aktie: So viel Gewinn hätte ein Quest Diagnostics-Investment von vor 3 Jahren abgeworfen (finanzen.at) | |
08.04.25 |
S&P 500-Titel Quest Diagnostics-Aktie: So viel hätten Anleger mit einem Investment in Quest Diagnostics von vor einem Jahr verdient (finanzen.at) | |
07.04.25 |
Erste Schätzungen: Quest Diagnostics legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
01.04.25 |
S&P 500-Wert Quest Diagnostics-Aktie: So viel Gewinn hätte eine Quest Diagnostics-Investition von vor 10 Jahren eingebracht (finanzen.at) |
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 152,00 | -1,04% |
|